Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/119666

Beta release

Statistics of Feasibility and efficacy of addition of individualized-dose lenalidomide to chlorambucil and rituximab as first-line treatment in elderly and FCR-unfit patients with advanced chronic lymphocytic leukemia
Statistics for this year
PeriodVisitsDownloads
202400
Statistics for the last 3 months
PeriodVisitsDownloads
2024-0600
2024-0700
2024-0800